Do Delirium and Alzheimer’s Dementia Share Specific Pathogenetic Mechanisms?
暂无分享,去创建一个
[1] P. McCracken. Delirium in Alzheimer's Disease , 2000 .
[2] W. Kamphorst,et al. Increased activity of surviving locus ceruleus neurons in Alzheimer's disease , 1999, Annals of neurology.
[3] P. Eikelenboom,et al. Inflammation and Alzheimer's Disease: Relationships between Pathogenic Mechanisms and Clinical Expression , 1998, Experimental Neurology.
[4] K. Jellinger,et al. Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease , 1998, Journal of Neural Transmission.
[5] P. Riederer,et al. Alzheimer's disease – synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts , 1998, Journal of Neural Transmission.
[6] S. Hoyer,et al. Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis , 1998, Journal of Neural Transmission.
[7] P. Mcgeer,et al. Inflammatory Cytokines in the CNS , 1997 .
[8] P. Hedera,et al. Delirium in Alzheimer Disease , 1997, Alzheimer disease and associated disorders.
[9] A. Hofman,et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study , 1997, The Lancet.
[10] Patrick L. McGeer,et al. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease , 1996, Neurology.
[11] H. D. de Vries,et al. Interleukin‐1 receptors on rat brain endothelial cells: a role in neuroimmune interaction? , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[12] D F Swaab,et al. Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. , 1995, The American journal of psychiatry.
[13] D F Swaab,et al. Image analyser-assisted morphometry of the locus coeruleus in Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis. , 1995, Brain : a journal of neurology.
[14] P. Eikelenboom,et al. Inflammatory mechanisms in Alzheimer's disease. , 1994, Trends in pharmacological sciences.
[15] J. Blalock,et al. The syntax of immune-neuroendocrine communication. , 1994, Immunology today.
[16] R. Ravid,et al. Decreased neuronal activity in the nucleus basalis of Meynert in Alzheimer's disease as suggested by the size of the Golgi apparatus , 1994, Neuroscience.
[17] G. Fricchione,et al. The immune-neuro-link and the macrophage: Postcardiotomy delirium, HIV-associated dementia and psychiatry , 1994, Progress in Neurobiology.
[18] L. Beckett,et al. Acute delirium and functional decline in the hospitalized elderly patient. , 1993, Journal of gerontology.
[19] J. Miller,et al. Delirium in the elderly. , 1993, Nursing.
[20] D. Evans,et al. Epidemiology of Delirium: An Overview of Research Issues and Findings , 1991, International Psychogeriatrics.
[21] J. Blass,et al. The Cellular Basis of Delirium and Its Relevance to Age-Related Disorders Including Alzheimer's Disease , 1991, International Psychogeriatrics.
[22] M. Vitek,et al. Interleukin-1β decreases acetylcholine measured by microdialysis in the hippocampus of freely moving rats , 1991, Brain Research.
[23] K. Blennow,et al. Confusional symptomatology distinguishes early— and late- onset Alzheimer’s disease , 1990, Aging.
[24] L. Aarden,et al. The relation among stress, adrenalin, interleukin 6 and acute phase proteins in the rat. , 1990, Clinical immunology and immunopathology.
[25] I Karlsson,et al. Blood‐brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors , 1990, Acta neurologica Scandinavica.
[26] K. Blennow,et al. Blood brain barrier function in vascular dementia , 1990, Acta neurologica Scandinavica.
[27] M. Mirmiran,et al. Alterations in the circadian rest-activity rhythm in aging and Alzheimer's disease , 1990, Biological Psychiatry.
[28] C. Gottfries. Neurochemical Aspects of Dementia Disorders , 1990 .
[29] K. Beyreuther,et al. A4 Protein in Alzheimer's Disease: Primary and Secondary Cellular Events in Extracellular Amyloid Deposition , 1989, Journal of neuropathology and experimental neurology.
[30] H. Soininen,et al. Delirium among elderly persons admitted to a psychiatric hospital: clinical course during the acute stage and one‐year follow‐up , 1989, Acta psychiatrica Scandinavica.
[31] I. Kushner. [35] The acute phase response: An overview , 1988 .
[32] I. Kushner,et al. The acute phase response: an overview. , 1988, Methods in enzymology.
[33] A. Dunn,et al. Systemic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism parallelling the increased plasma corticosterone. , 1988, Life sciences.
[34] Z. J. Lipowski. Delirium (acute confusional states). , 1990, JAMA.
[35] D. Cohen,et al. Ventricular fluid interleukin-1 activity in patients with head injury. , 1987, The Journal of laboratory and clinical medicine.
[36] D. F. Swaab,et al. The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia , 1985, Brain Research.
[37] E. Peskind,et al. Dexamethasone suppression test and cortisol circadian rhythm in primary degenerative dementia. , 1982, The American journal of psychiatry.
[38] J. R. Sanford. Tolerance of debility in elderly dependants by supporters at home: its significance for hospital practice. , 1975, British medical journal.
[39] T. Itil,et al. ANTICHOLINERGIC DRUG‐INDUCED DELIRIUM: EXPERIMENTAL MODIFICATION, QUANTITATIVE EEG AND BEHAVIORAL CORRELATIONS , 1966, The Journal of nervous and mental disease.
[40] Kral Va. Stress and mental disorders of the senium. , 1962 .
[41] V. A. Kral. Stress and mental disorders of the senium. , 1962, Medical services journal, Canada.
[42] G. L. Engel,et al. Delirium, a syndrome of cerebral insufficiency. , 1959, Journal of chronic diseases.